Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Equity Average (2024 - 2025)

Historic Equity Average for Inhibrx Biosciences (INBX) over the last 2 years, with Q3 2025 value amounting to $52.7 million.

  • Inhibrx Biosciences' Equity Average fell 7350.92% to $52.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.7 million, marking a year-over-year decrease of 7350.92%. This contributed to the annual value of $88.5 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Inhibrx Biosciences' Equity Average stood at $52.7 million, which was down 7350.92% from $81.5 million recorded in Q2 2025.
  • In the past 5 years, Inhibrx Biosciences' Equity Average ranged from a high of $198.9 million in Q3 2024 and a low of $52.7 million during Q3 2025